Accelerated partial-breast irradiation with high-dose-rate brachytherapy: Mature results of a Phase II trial-Reference-Cited by-同舟云学术

Accelerated partial-breast irradiation with high-dose-rate brachytherapy: Mature results of a Phase II trial

Published:2019-09 Issue:5 Volume:18 Page:627-634
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Maranzano Ernesto,Arcidiacono Fabio,Italiani Marco,Anselmo Paola,Casale Michelina,Terenzi Sara,Di Marzo Alessandro,Fabiani Stefania,Draghini Lorena,Trippa Fabio

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference51 articles.

1. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials. Early Breast Cancer Trialists' Collaborative Group (EBCTCG);Darby;Lancet,2011

2. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomyin early breast cancer in The Netherlands: a population-based study;van Maaren;Lancet Oncol,2016

3. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomized phase 3 trial;Bartelink;Lancet Oncol,2015

4. Alternatives to standard fractionation radiation therapy after lumpectomy: hypofractionated whole-breast irradiation and accelerated partial-breast irradiation;Ohri;Surg Oncol Clin N Am,2018

5. START Trialists' Group the UK Standardization of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial;Bentzen;Lancet Oncol,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDR-brachytherapy for accelerated partial breast irradiation: Long-term experience from a Japanese institution;Journal of Contemporary Brachytherapy;2023

2. The Role of Interstitial Brachytherapy for Breast Cancer Treatment: An Overview of Indications, Applications, and Technical Notes;Cancers;2022-05-23